Welcome to our dedicated page for Life360 SEC filings (Ticker: LIF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Life360, Inc. filings document regulatory disclosures for a Delaware technology company whose common stock trades on Nasdaq under LIF. Form 8-K reports furnish operating and financial results, Regulation FD presentation materials, material-event disclosures, material agreements, shareholder voting matters and capital-structure information.
Proxy materials describe board and executive compensation matters, equity awards, corporate governance and voting procedures. The filing record also reflects disclosure areas tied to Life360’s family safety platform, subscription metrics, advertising initiatives, legal and compliance oversight, and public-company securities reporting.
Life360, Inc. director reported an insider transaction involving stock options and common shares. On 12/15/2025, the director exercised a stock option to acquire 7,930 shares of common stock at $11.18 per share, then sold 7,930 shares of common stock at $68.3 per share under transaction codes M and S.
After these transactions, the director beneficially owned 105,456 shares of common stock, including 1,357 restricted stock units that each convert into one share upon vesting, and held 87,230 stock options at an exercise price of $11.18 per share. The filing states the trades were made under a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025, and also corrects previously misreported vesting terms for the stock option.
Life360, Inc. Chief Financial Officer Russell John Burke reported an option exercise and related share holdings update. On 12/15/2025, he exercised a stock option to buy 2,500 shares of Life360 common stock at an exercise price of $3.58 per share, classified as transaction code "M". Following this transaction, he beneficially owned 90,754 shares directly and 72,553 shares indirectly through the Russell John Burke Revocable Trust.
The directly held amount includes 72,230 restricted stock units, each representing a contingent right to receive one share of common stock upon vesting. After the exercise, Burke also held 431,514 stock options directly, and the reported option is noted as fully vested and exercisable with an expiration date of 05/19/2030.
Life360, Inc. director John Coghlan reported an insider transaction involving stock options and common stock. On 12/12/2025, he acquired 920 shares of common stock through the exercise of a stock option with an exercise price of $2.15, reflected with transaction code "M".
After the transaction, he beneficially owns 2,592 shares directly, plus 10,737 shares held by the John Coghlan Living Trust and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. His derivative holdings include 142,306 stock options. The footnotes state that 1,672 directly held shares were transferred to the John Coghlan Living Trust under an exemption, that 2,592 direct holdings include 1,672 restricted stock units, and that the reported stock option is fully vested and exercisable.
Life360, Inc. director John Coghlan reported sales, transfers and a charitable gift of company common stock. On 12/05/2025, the John Coghlan Living Trust sold 2,025 shares at a weighted average price of $76.82 and 1,100 shares at a weighted average price of $77.96, in each case under a Rule 10b5-1 trading plan adopted on December 6, 2024.
On 12/09/2025, he made a bona fide gift of 3,045 shares to a donor-advised fund for charitable purposes and transferred 3,045 shares between the John Coghlan Living Trust and The John Philip Coghlan 2025 Grantor Retained Annuity Trust in transactions described as exempt under Rule 16a-13.
Following these transactions, he beneficially owns 3,344 shares directly, 9,065 shares through the John Coghlan Living Trust and 55,494 shares through The John Philip Coghlan 2025 Grantor Retained Annuity Trust, including 1,672 restricted stock units that each represent one share upon vesting.
Life360, Inc.'s Chief Financial Officer reported a tax-related share withholding. On 12/04/2025, the issuer withheld 9,978 shares of common stock at $75.02 per share to satisfy income tax withholding and remittance obligations arising from the vesting and net settlement of previously granted restricted stock units, rather than an open-market sale.
After this transaction, the officer beneficially owned 88,254 shares of Life360 common stock directly and 72,553 shares indirectly through the Russell John Burke Revocable Trust. These holdings also include 72,230 restricted stock units previously granted, each representing a contingent right to receive one share of common stock upon vesting.
Life360, Inc. reported that one of its directors sold common stock in the company. On 12/03/2025, the director sold 15,000 shares of Life360 common stock at a weighted average price of $74.19 per share, with individual trade prices ranging from $74.13 to $74.46. After this transaction, the director beneficially owns 56,809 shares indirectly through the Goines Wong Living Trust and 6,070 shares directly. The direct holdings include 2,339 restricted stock units, each representing the right to receive one share of common stock upon vesting.
Life360, Inc. (LIF) CEO and director reports a small stock sale under a preset trading plan. On 11/24/2025, the reporting person sold 4,546 shares of Life360 common stock at a price of $76.1 per share, coded as an "S" transaction. This sale was made pursuant to a Rule 10b5-1 trading plan adopted on November 27, 2024, which provides for automatic sales based on predetermined criteria and was put in place when the insider was not aware of material nonpublic information.
After this transaction, the insider beneficially owns 324,827 shares of Life360 common stock, including 222,277 restricted stock units that each represent a contingent right to receive one share upon vesting.
Life360, Inc. (LIF) Chief Financial Officer updates holdings and corrects prior option terms. The reporting person exercised a stock option and acquired 6,500 shares of Life360 common stock on 11/19/2025 at an exercise price of $3.58 per share. After the transaction, the reporting person directly held 98,232 common shares and indirectly held 72,553 shares through the Russell John Burke Revocable Trust.
The filing notes that 9,523 directly held shares were previously transferred to the revocable trust under an exemption from Section 16. It also states that 91,732 restricted stock units are included in the beneficial ownership total, each representing a right to receive one common share upon vesting. The stock option underlying this exercise is now fully vested and exercisable, and the vesting terms previously reported for this option were inadvertently misreported and are corrected in this filing.
Life360, Inc. (LIF) reported that one of its directors exercised and sold shares under a pre-arranged trading plan. On 11/13/2025, the director exercised a stock option to acquire 7,930 shares of common stock at $11.18 per share and, on the same date, sold 7,930 shares of common stock at $76.93 per share. After these transactions, the director beneficially owned 105,456 shares of common stock, including 2,036 restricted stock units, and held 95,160 stock options. The filing notes that these trades were executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, and it corrects the vesting commencement date of the reported stock option to April 1, 2024.
Life360, Inc. announced a planned acquisition of Nativo, Inc. via a Merger Agreement valued at approximately $120 million in a mix of cash and common stock. The transaction is subject to customary closing conditions and is expected to close in January 2026.
The company also furnished materials related to its results and investor communications, including a media release (Exhibit 99.1) and an investor presentation (Exhibit 99.2) tied to a conference call and webcast on November 10, 2025 at 5:00 p.m. Eastern Time. A separate press release (Exhibit 99.3) announced the Nativo deal. These materials are furnished, not filed, under the Exchange Act.
Forward-looking statements highlight anticipated benefits and synergies from integrating Nativo, along with potential acceleration of Life360’s advertising strategy, while noting risks related to closing conditions, integration, and market factors.